RxNorm 1806931 NDC Crossover
PANCREAZE 21,000 UNT / 83,900 UNT / 54,700 UNT Delayed Release Oral Capsule
Related NDC Codes to RxNorm Concept 1806931
The following NDC codes crossover to the RxNorm Concept 1806931. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
|---|---|---|---|---|---|---|---|
| 62541-401 | Pancreaze | Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease | Capsule, Delayed Release | Oral | Vivus Llc | ACTIVE | |
| 62541-402 | Pancreaze | Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease | Capsule, Delayed Release | Oral | Vivus Llc | ACTIVE | |
| 62541-403 | Pancreaze | Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease | Capsule, Delayed Release | Oral | Vivus Llc | ACTIVE | |
| 62541-404 | Pancreaze | Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease | Capsule, Delayed Release | Oral | Vivus Llc | ACTIVE | |
| 62541-405 | Pancreaze | Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease | Capsule, Delayed Release | Oral | Vivus Llc | ACTIVE | |
| 62541-406 | Pancreaze | Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease | Capsule, Delayed Release | Oral | Vivus Llc | ACTIVE |
